×
A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol
Nicum S., Roberts C., Boyle L., Kopijasz S., Gourley C., Hall M., Montes A., Poole C., Collins L., Schuh A., Dutton SJ.
DOI
10.1186/1471-2407-14-983
Type
Journal article
Journal
BMC Cancer
Publisher
Springer Nature
Publication Date
12/2014
Volume
14